Literature DB >> 23851678

Endometrial thickness measured by ultrasonography in postmenopausal patients with endometrial carcinoma has significance, irrespective of histological subtype.

Ayako Hosoi1, Yutaka Ueda, Mariko Shindo, Satoshi Nakagawa, Shinya Matsuzaki, Eiji Kobayashi, Toshihiro Kimura, Kiyoshi Yoshino, Masami Fujita, Tadashi Kimura.   

Abstract

OBJECTIVE: The criterion standard of practice for gynecologists is to measure the endometrial thickness with ultrasonography in women presenting with postmenopausal bleeding. A recent study reported that a thin endometrial stripe upon ultrasonography did not reliably exclude type II endometrial carcinoma. The aim of the present study was to reevaluate the reliability of ultrasonographic measurement of the endometrium for prediction of endometrial carcinomas of both types I and II in postmenopausal women.
METHODS: We collected clinical data from patients with endometrial carcinoma who underwent surgical treatment at the Department of Obstetrics and Gynecology of the Osaka University Hospital, Osaka, Japan, during our study period from 2010 to 2012. Only the postmenopausal cases were included in our study. We excluded cases with insufficient clinical data.
RESULTS: Preoperative measurement of the endometrium by transvaginal ultrasonography revealed that the endometrium was greater than 4 mm in 80 (89%) of the 90 type I cases and in 41 (93%) of the 44 type II cases. The median of the endometrial thickness measured with transvaginal ultrasonography preoperatively in type I cases, including both patients with myometrial invasion less than 1/2 and those with myometrial invasion greater than 1/2, was 13 mm (range, 1-78 mm). That of type II cases was 15 mm (range, 1-54 mm). This difference was not statistically significant (P = 0.46 by Mann-Whitney U test). These results implied that endometrial thickness was not significantly associated with the type of tumors.
CONCLUSIONS: Ultrasonographic measurements of the endometrium for prediction of endometrial carcinomas in postmenopausal women are reliable for both type I and type II tumors. These results encourage us to continue to use the "4-mm (5-mm) rule" to evaluate endometrial thickness in postmenopausal women, in opposition to a previous report.

Entities:  

Mesh:

Year:  2013        PMID: 23851678     DOI: 10.1097/IGC.0b013e31829f1857

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

1.  Association between IL-6 Gene (-174 & -572 G/C) Polymorphisms and Endometrial Adenocarcinoma Risk.

Authors:  Hai-Ying Wang; Jin-Jun Zhang; Xiang-Yu Zheng; Jian-Hua Liu; Yong-Wei Li
Journal:  Pathol Oncol Res       Date:  2016-05-19       Impact factor: 3.201

2.  Research into the Value of B-Mode Ultrasound, CT and MRI Examinations in the Diagnosis of Preoperative Myometrial Infiltration of Endometrial Cancer and Lymph Node Metastasis.

Authors:  Ren Lu; Sun Guixia
Journal:  Open Med (Wars)       Date:  2015-12-17

3.  Risk of malignancies among asymptomatic postmenopausal women with thickened endometrium: A cohort study.

Authors:  Zhe Li; Lei Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

4.  Evaluation of menopausal endometrial lesions via mathematical modeling clinical indicators and ultrasonographic parameters.

Authors:  Yamei Zhu; Lei Tang; Qiao Chen; Man Chen
Journal:  Technol Health Care       Date:  2022       Impact factor: 1.205

5.  A case of laparoscopic surgery for endometrial cancer in a patient previously treated with a transvaginal mesh procedure for pelvic organ prolapse.

Authors:  Kiyoshi Yoshino; Eiji Kobayashi; Masayuki Endo; Mamoru Kakuda; Aiko Okada; Takuji Tomimatsu; Kenjiro Sawada; Masahiko Takemura; Tadashi Kimura
Journal:  Gynecol Minim Invasive Ther       Date:  2017-04-15

6.  Risk factors and sonographic endometrial thickness as predictors of tumour stage and histological subtype of endometrial cancer.

Authors:  Ivana Rizzuto; Rachel Nicholson; Wendy S MacNab; Mythili Nalam; Rohit Sharma; Barnaby Rufford
Journal:  Gynecol Oncol Rep       Date:  2019-08-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.